Taylor Tate Deborah 4

What Happened

• Deborah Taylor Tate, a director of HealthStream, had 3,148 restricted stock units (RSUs vest) on June 8, 2026 and converted those RSUs into 3,148 shares of common stock (reported as derivative conversion, code M). The filing also shows three derivative disposals on the same date totaling 3,148 shares (1,126; 1,006; 1,016), each at $0.00. No cash paid or received is reported for these transactions.
• This is an award/vesting event (compensation), not an open-market purchase or a voluntary sale. The pattern—gross shares converted and an equal number disposed—is consistent with shares being withheld to satisfy tax or similar obligations rather than a market sale.

Key Details

• Transaction date: June 8, 2026 (filed June 9, 2026) — filing appears timely.
• Acquired: 3,148 shares via RSU vesting (exercise/conversion, code M) at $0.00 per share.
• Disposed: 1,126; 1,006; and 1,016 shares (total 3,148) on same date at $0.00 per share (reported as derivative dispositions).
• Shares owned after the transactions: not specified in the provided filing details.
• Relevant footnotes:
  • F1–F2: Shares were acquired on RSU vesting; each RSU converts to one share.
  • F3–F6: RSUs are subject to a three-year vesting schedule with annual vesting (vesting start dates noted in footnotes).
• No 10b5-1 plan, gift, or explicit tax-withholding footnote is listed in the excerpt; however, the matching disposal amounts are consistent with withholding for taxes or related settlement.

Context

• For retail investors: this filing reflects routine equity compensation vesting for a director. It does not indicate an outright market sale or a new purchase position. Purchases by insiders are often more indicative of bullish sentiment; vesting and withholding are standard compensation events and should be interpreted as such.